Cerus Corporation is a developer of novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly within the fields of cancer, infectious disease and blood safety. Additionally, the company is employing its proprietary antigens to develop new therapies for cancer, infectious disease and blood safety. In addition, the company has three therapeutic cancer vaccine products in development using its Listeria vaccine platform and other platforms. The company is located in Concord, Calif.